Skip to main content
Institute for Health Metrics and Evaluation
Contact us
Research library
Data catalog
Give now
IHME logo
Main navigation
Research and analysis
Close
Research and analysis overview
Health topics
Air pollution
Alcohol use
Antimicrobial resistance (AMR)
Burden of Proof
Child health
COVID-19
Diet
HIV/AIDS
Maternal health
Mental health
Smoking and tobacco
Vaccine coverage
Global Burden of Disease (GBD) study
GBD home
GBD Collaborator Network
Disease, injury, and risk factsheets
Health by location
Country profiles
US health
Health policy and planning
Health financing
Health forecasting
Program and policy evaluations
Program in Cardiovascular Health Metrics
Training and workshops
Explore all publications
Data tools and practices
Close
Data tools and practices overview
Explore our data tools
Data sources catalog
Interactive data visuals
Verbal autopsy tool
Data practices
How we collect data
Data transparency
Data use agreement
Terms and conditions
Data for the private sector
News and events
Close
Newsroom
Blog
Media
News releases
IHME in the news
Global Health Insights Podcast
Videos
Events
About us
Close
About IHME
Who we are
Vision, mission, values, and principles
Diversity, Equity, and Inclusion (DEI)
Our people
Governance
Work with us
Benefits
Employee blog
How we hire
Job openings
Awarding innovative research
GBD Emerging Researcher
Roux Prize
Partnerships
Contact us
Give now
Search
Menu
Breadcrumb
Home
Global Burden of Disease (GBD)
GBD 2021 Methods Appendices
Interstitial lung disease and pulmonary sarcoidosis (ILD)
Back to top
Subscribe to our newsletter
Email Address
